Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A terrible beauty: a physician's story of ovarian cancer.

Literature DB >> 17872763

A terrible beauty: a physician's story of ovarian cancer.

Linda J Spano.

Abstract

Entities: Disease

Mesh：

Year: 2007 PMID： 17872763 PMCID： PMC1949193

Source DB: PubMed Journal: Can Fam Physician ISSN： 0008-350X Impact factor: 3.275

Keyword Cloud
References

× No keyword cloud information.

18 in total

1. Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5.

Authors: M A Bookman; B E Greer; R F Ozols
Journal: Int J Gynecol Cancer Date: 2003 Nov-Dec Impact factor: 3.437

Review 2. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.

Authors:
Journal: Ann Intern Med Date: 2005-09-06 Impact factor: 25.391

Review 3. Angiogenesis in ovarian cancer: molecular pathology and therapeutic strategies.

Authors: Pamela J Paley
Journal: Curr Oncol Rep Date: 2002-03 Impact factor: 5.075

Review 4. Epidermal growth factor receptor inhibitors for the treatment of epithelial ovarian cancer.

Authors: Stephanie V Blank; Richard Chang; Franco Muggia
Journal: Oncology (Williston Park) Date: 2005-04 Impact factor: 2.990

Review 5. Advances in the management of epithelial ovarian cancer.

Authors: Anna Berkenblit; Stephen A Cannistra
Journal: J Reprod Med Date: 2005-06 Impact factor: 0.142

6. Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer.

Authors: David B Agus; Michael S Gordon; Charles Taylor; Ronald B Natale; Beth Karlan; David S Mendelson; Michael F Press; David E Allison; Mark X Sliwkowski; Gracie Lieberman; Stephen M Kelsey; Gwen Fyfe
Journal: J Clin Oncol Date: 2005-02-07 Impact factor: 44.544

7. A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.

Authors: Mark H Greene; Marion Piedmonte; Dave Alberts; Mitchell Gail; Martee Hensley; Zoe Miner; Phuong L Mai; Jennifer Loud; Gustavo Rodriguez; Jack Basil; John Boggess; Peter E Schwartz; Joseph L Kelley; Katie E Wakeley; Lori Minasian; Stephen Skates
Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-03 Impact factor: 4.254